XM17
- Generic Name
- XM17
Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Merckle GmbH
- Target Recruit Count
- 49
- Registration Number
- NCT02592031
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath